Optogenetic inhibition of overactive neuronal activity
AssigneeEmory University
InventorsRobert E. Gross, Nealan G. Laxpati
Life of this patent
Estimating the term…
Abstract
This disclosure relates to recombinant proteins, vectors, and methods of treating neurological conditions by exposing neurons to an opsin and luciferase in the presence of a luciferin. In certain embodiments, the disclosure relates to treating or preventing epilepsy or seizures comprising administering an effective amount of a vector that encodes an opsin and luciferase in combination with a luciferin to a subject in need thereof.
Claims16
A recombinant protein comprising a light-activated opsin and a luciferase.
A vector comprising a recombinant nucleic acid encoding a light-activated opsin and encoding a luciferase.
Dependencies are inferred from the claim text.